Rezultati pretraživanja
  1. prije 22 sata

    Genprex prioritizing Oncoprex development in combo with AstraZeneca’s Tagrisso to treat non-small cell lung cancer via

  2. 31. sij

    2 wild moves up in 1 day 3 Trades - 3 Wins for us Next one please!

  3. 29. sij

    momentum continuing. Price up another 16.43% since last mention. First mentioned at 08:25 AM ET. Now trading at $1.63.

  4. 24. sij

    I had a few loses this week, but still a solid 1300$ week gain. Winning trades with and

  5. 24. sij

    Full interview: Genprex gets FDA Fast Track for its Oncoprex combination therapy, raises $8M via

  6. 24. sij

    is up 12.95% on 219,838 volume. Now trading at $1.57.

  7. 24. sij

    Hey guys im just putting this out there. is trading at a 52 week low looking for a nice pop back up! Look at Sabby management increase in shares in just days apart!

  8. 23. sij

    Bought again today. They’re FDA approved and going through guidelines. Should be a huge profit in the next few days.

  9. 22. sij

    GNPX SHORT INTEREST ALERT: THERE IS A 24% SHORT FLOAT AND THE STOCK IS TRENDING UP IN THE PREMARKET! GNPX Short Interest / Genprex, Inc.

  10. Odgovor korisniku/ci

    Lol

  11. 20. ruj 2019.

    Full interview: Genprex's active drug ingredient validated by independent medical journal 'Nature Medicine' via

  12. 6. kol 2019.

    Genprex says partner successfully completes manufacturing of TUSC2 plasmid DNA for Oncoprex gene therapy treatment via

  13. 3. srp 2019.

    The Team had the opportunity to get together and strategize on a few upcoming company initiatives in our Cambridge, MA office this week. It was a busy but productive few days!

  14. 21. ožu 2019.

    President & COO, will be giving a presentation at ARM’s Cell & Gene Therapy Investor Day in 20 minutes! Please join us in the Main Bar Room of the Metropolitan Club at One East 60th Street, NYC for a chance to meet Julien and ask any questions you might have

  15. 20. stu 2018.

    Genprex, Aldevron report progress in clinical trials for lung-cancer therapy Oncoprex via

  16. 13. stu 2018.

    Genprex strengthens its team with new VP of clinical operations via

  17. 17. lis 2018.

    How Genprex took an abandoned pipeline drug and turned it into Oncoprex, an innovative treatment for non-small cell lung cancer via

  18. 10. ruj 2018.

    Last week, Genprex presented at the HC Wainwright Conference at the St. Regis Hotel in NYC. The presentation is available here:

  19. 10. ruj 2018.

    Genprex CEO updates investors on recent $10mln capital raise, progress of cancer-fighting drug Oncoprex via

  20. 30. kol 2018.

    Genprex to Present at Upcoming Investor Conferences in New York.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.